M. Sloan Siegrist
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
M. Sloan Siegrist has a total of 186 co-authors. Here are the top co-authors by number of shared publications:
- Yasu S. Morita
Department of Microbiology, University of Massachusetts Amherst
12 shared publications - Irene Lepori
Department of Microbiology, University of Massachusetts Amherst, Amherst, USA
7 shared publications - Benjamin M. Swarts
Department of Chemistry and Biochemistry, Central Michigan University, Mount Pleasant, MI, USA
6 shared publications Takehiro Kado
6 shared publications- Takehiro Kado
Department of Biology, Missouri State University
6 shared publications Irene Lepori
University of Massachusetts Amherst
5 shared publications
Latest Publications
- Open Access
- 18 September 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (11)
Metabolic flexibility and an unusual route for peptidoglycan muramic acid recycling in mycobacteria
- 18 September 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (11)
Open AccessMetabolic flexibility and an unusual route for peptidoglycan muramic acid recycling in mycobacteria
- Open Access
- 20 August 2026
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 208 (8) , e0024026
ag85A loss promotes free mycolate accumulation and sensitizes plasma membrane domain to disruption
The mycomembrane of mycobacteria, which is composed primarily of long-chain mycolic acids, is critical for cell survival, structural integrity, and resistance to environmental stress; however, its underlying synthesis mechanisms remain incompletely understood. This study investigated the role of the mycolyltransferase Ag85A, a key enzyme in mycomembrane synthesis, in regulating plasma membrane domains and cell envelope organization in Mycobacterium smegmatis . Using ∆ ag85A deletion mutants, we combined microscopy, subcellular fractionation, mass spectrometry, and lipid analysis to evaluate changes in membrane structure, intracellular chemical accumulation, and lipid composition. The deletion of ag85A led to destabilization of the plasma membrane domain, increased chemical accumulation, and altered cell envelope lipid compositions. Consistent with prior studies, Δ ag85A accumulated mycolates, specifically in the free lipid pool rather than in the covalently linked cell wall fractions. In addition, the accumulation of an uncharacterized glycolipid species was absent or reduced in the wild-type and complemented strains; these findings indicate that Ag85A loss alters the distributions of mycolic acid-containing lipids and is associated with destabilization of the plasma membrane domain, highlighting a functional link between the processes of lipids and plasma membrane architecture. IMPORTANCE: The unique cell envelope of mycobacteria plays a vital role in survival by protecting against immune responses and antibiotic treatments. In this study, we examined the consequences of deleting ag85A , a well-characterized mycolyltransferase that contributes to the assembly of the mycomembrane lipid layer. In addition to known phenotypes, such as increased drug sensitivity and disrupted biofilm formation, our data reveal alterations in membrane-associated lipid distributions and suggest a possible link between membrane synthesis and plasma membrane organization. These findings provide new insight into the broader cellular impact of Ag85A loss and suggest avenues for further investigation into how lipid biosynthesis interfaces with membrane architecture. Understanding this relationship may inform new therapeutic strategies that destabilize the protective envelope of pathogenic mycobacteria.
- 20 August 2026
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 208 (8) , e0024026
Open Accessag85A loss promotes free mycolate accumulation and sensitizes plasma membrane domain to disruption
The mycomembrane of mycobacteria, which is composed primarily of long-chain mycolic acids, is critical for cell survival, structural integrity, and resistance to environmental stress; however, its underlying synthesis mechanisms remain incompletely understood. This study investigated the role of the mycolyltransferase Ag85A, a key enzyme in mycomembrane synthesis, in regulating plasma membrane domains and cell envelope organization in Mycobacterium smegmatis . Using ∆ ag85A deletion mutants, we combined microscopy, subcellular fractionation, mass spectrometry, and lipid analysis to evaluate changes in membrane structure, intracellular chemical accumulation, and lipid composition. The deletion of ag85A led to destabilization of the plasma membrane domain, increased chemical accumulation, and altered cell envelope lipid compositions. Consistent with prior studies, Δ ag85A accumulated mycolates, specifically in the free lipid pool rather than in the covalently linked cell wall fractions. In addition, the accumulation of an uncharacterized glycolipid species was absent or reduced in the wild-type and complemented strains; these findings indicate that Ag85A loss alters the distributions of mycolic acid-containing lipids and is associated with destabilization of the plasma membrane domain, highlighting a functional link between the processes of lipids and plasma membrane architecture. IMPORTANCE: The unique cell envelope of mycobacteria plays a vital role in survival by protecting against immune responses and antibiotic treatments. In this study, we examined the consequences of deleting ag85A , a well-characterized mycolyltransferase that contributes to the assembly of the mycomembrane lipid layer. In addition to known phenotypes, such as increased drug sensitivity and disrupted biofilm formation, our data reveal alterations in membrane-associated lipid distributions and suggest a possible link between membrane synthesis and plasma membrane organization. These findings provide new insight into the broader cellular impact of Ag85A loss and suggest avenues for further investigation into how lipid biosynthesis interfaces with membrane architecture. Understanding this relationship may inform new therapeutic strategies that destabilize the protective envelope of pathogenic mycobacteria.
- Open Access
- 30 June 2026
- Published by Springer Nature in Nature Microbiology
- Vol. 11 (9) , 1-19
Identification of chemical features for improved outer membrane permeation in mycobacteria using machine learning
The ability of compounds to permeate and accumulate in bacterial cells is a critical determinant of antibiotic efficacy. Better therapeutics are urgently needed for the human pathogen Mycobacterium tuberculosis , yet the cell envelope, including the mycobacterial outer membrane, represents a significant barrier for drug entry, and the chemical features governing permeation remain poorly understood. Here we used the bioorthogonal click chemistry-based PAC-MAN assay to profile mycomembrane permeation of 1,572 azide-tagged compounds in M. tuberculosis and the model organism M. smegmatis . Cheminformatics and machine learning identified chemical features associated with mycomembrane permeation, which in turn had predictive value in three molecule series. Chemical predictors of mycomembrane permeation include nitrogen-containing aromatic scaffolds, such as indole, which in some cases were associated with increased anti- M. tuberculosis activity. Our data suggest a rational framework for improving mycomembrane permeation and whole-cell activity of antibiotics targeting M. tuberculosis .
- 30 June 2026
- Published by Springer Nature in Nature Microbiology
- Vol. 11 (9) , 1-19
Open AccessIdentification of chemical features for improved outer membrane permeation in mycobacteria using machine learning
The ability of compounds to permeate and accumulate in bacterial cells is a critical determinant of antibiotic efficacy. Better therapeutics are urgently needed for the human pathogen Mycobacterium tuberculosis , yet the cell envelope, including the mycobacterial outer membrane, represents a significant barrier for drug entry, and the chemical features governing permeation remain poorly understood. Here we used the bioorthogonal click chemistry-based PAC-MAN assay to profile mycomembrane permeation of 1,572 azide-tagged compounds in M. tuberculosis and the model organism M. smegmatis . Cheminformatics and machine learning identified chemical features associated with mycomembrane permeation, which in turn had predictive value in three molecule series. Chemical predictors of mycomembrane permeation include nitrogen-containing aromatic scaffolds, such as indole, which in some cases were associated with increased anti- M. tuberculosis activity. Our data suggest a rational framework for improving mycomembrane permeation and whole-cell activity of antibiotics targeting M. tuberculosis .
- Open Access
Metabolic flexibility and an unusual route for peptidoglycan muramic acid recycling in mycobacteria
De novo biosynthesis of cell wall peptidoglycan is essential for bacterial viability under many growth conditions and is a well-validated antibiotic target. Although generally not essential for bacterial fitness under standard laboratory growth conditions, peptidoglycan recycling can aid bacterial survival under host or antibiotic stress. Peptidoglycan consists of alternating sugars N -acetylmuramic acid (Mur N Ac) and N -acetylglucosamine (Glc N Ac) cross-linked by peptides. Recycling of these sugars can proceed via Glc N Ac and glucosamine intermediates ( Escherichia coli -type) or, in the case of Mur N Ac, bypass these intermediates altogether ( Pseudomonas -type). We serendipitously discovered that the pathogen Mycobacterium tuberculosis and model organism M. smegmatis assimilate 2-modified Mur N Ac probes into their peptidoglycan despite lacking the Pseudomonas -type machinery that is normally required for incorporation of these molecules. Our data suggest that unmodified and 2-modified Mur N Ac incorporate into M. smegmatis peptidoglycan via multiple pathways, the former preferentially via an E. coli -type route and the latter preferentially via a non- E. coli , non- Pseudomonas -type route with Glc N Ac but not glucosamine intermediates. These findings reveal metabolic flexibility in mycobacterial cell wall recycling that encompasses a previously undescribed pathway. Importance: Cell wall biosynthesis is critical for bacterial replication under many conditions and is a successful drug target. Recycling of cell wall components is often dispensable under laboratory conditions but can promote bacterial survival under stress. We find that mycobacterial species can recycle a cell wall sugar via a mechanism distinct from those used by other bacteria. As pathogenic mycobacteria are subject to stress from the host environment and antibiotics, this mechanism is a potential novel vulnerability for these organisms.
Open AccessMetabolic flexibility and an unusual route for peptidoglycan muramic acid recycling in mycobacteria
De novo biosynthesis of cell wall peptidoglycan is essential for bacterial viability under many growth conditions and is a well-validated antibiotic target. Although generally not essential for bacterial fitness under standard laboratory growth conditions, peptidoglycan recycling can aid bacterial survival under host or antibiotic stress. Peptidoglycan consists of alternating sugars N -acetylmuramic acid (Mur N Ac) and N -acetylglucosamine (Glc N Ac) cross-linked by peptides. Recycling of these sugars can proceed via Glc N Ac and glucosamine intermediates ( Escherichia coli -type) or, in the case of Mur N Ac, bypass these intermediates altogether ( Pseudomonas -type). We serendipitously discovered that the pathogen Mycobacterium tuberculosis and model organism M. smegmatis assimilate 2-modified Mur N Ac probes into their peptidoglycan despite lacking the Pseudomonas -type machinery that is normally required for incorporation of these molecules. Our data suggest that unmodified and 2-modified Mur N Ac incorporate into M. smegmatis peptidoglycan via multiple pathways, the former preferentially via an E. coli -type route and the latter preferentially via a non- E. coli , non- Pseudomonas -type route with Glc N Ac but not glucosamine intermediates. These findings reveal metabolic flexibility in mycobacterial cell wall recycling that encompasses a previously undescribed pathway. Importance: Cell wall biosynthesis is critical for bacterial replication under many conditions and is a successful drug target. Recycling of cell wall components is often dispensable under laboratory conditions but can promote bacterial survival under stress. We find that mycobacterial species can recycle a cell wall sugar via a mechanism distinct from those used by other bacteria. As pathogenic mycobacteria are subject to stress from the host environment and antibiotics, this mechanism is a potential novel vulnerability for these organisms.
- Open Access
Loss of Ag85A disrupts plasma membrane domains and promotes free mycolic acid accumulation in mycobacteria
Summary: The mycomembrane of mycobacteria, composed primarily of long-chain mycolic acids, is critical for cell survival, structural integrity, and resistance to environmental stress, yet its underlying synthesis mechanisms remain incompletely understood. This study investigates the role of Ag85A, a key enzyme in mycomembrane synthesis, in regulating plasma membrane domains and cell envelope organization in Mycobacterium smegmatis . Using Δ Ag85A deletion mutants, we combined microscopy, biochemical assays, thin-layer chromatography, and lipid analysis to evaluate changes in membrane structure, chemical accumulation, and lipid composition. Ag85A deletion leads to altered plasma membrane domain organization, increased chemical accumulation, changes in cell envelope lipid composition. Unexpectedly, lipid analysis revealed accumulation—not depletion—of mycolic acids in the mutant, suggesting that increased permeability is not directly due to mycolic acid loss. These findings highlight a novel link between mycomembrane composition and plasma membrane domain stability. Our study not only advances understanding of mycobacterial cell envelope architecture but also identifies potential targets for enhancing drug penetration in resistant mycobacterial infections. Significance: The unique cell envelope of mycobacteria is central to survival, enabling it to resist immune defenses and antibiotic treatment. In this study, we reveal a novel function of Ag85A, a synthase of outmost layer of mycobacteria beyond its known role in mycolyltransferase activity: it is essential for the formation of plasma membrane domains that orchestrate cell envelope synthesis. By structuring plasma membrane domains, Ag85A contributes directly to the resilience of the cell envelope, reinforcing mycobacterial survival mechanisms under hostile conditions. Our findings provide a pivotal insight into mycobacterial cell biology, with broad implications for therapeutic development. Disrupting Ag85A-dependent membrane domain formation could weaken the protective cell envelope, offering a promising approach to enhance current treatments.
Open AccessLoss of Ag85A disrupts plasma membrane domains and promotes free mycolic acid accumulation in mycobacteria
Summary: The mycomembrane of mycobacteria, composed primarily of long-chain mycolic acids, is critical for cell survival, structural integrity, and resistance to environmental stress, yet its underlying synthesis mechanisms remain incompletely understood. This study investigates the role of Ag85A, a key enzyme in mycomembrane synthesis, in regulating plasma membrane domains and cell envelope organization in Mycobacterium smegmatis . Using Δ Ag85A deletion mutants, we combined microscopy, biochemical assays, thin-layer chromatography, and lipid analysis to evaluate changes in membrane structure, chemical accumulation, and lipid composition. Ag85A deletion leads to altered plasma membrane domain organization, increased chemical accumulation, changes in cell envelope lipid composition. Unexpectedly, lipid analysis revealed accumulation—not depletion—of mycolic acids in the mutant, suggesting that increased permeability is not directly due to mycolic acid loss. These findings highlight a novel link between mycomembrane composition and plasma membrane domain stability. Our study not only advances understanding of mycobacterial cell envelope architecture but also identifies potential targets for enhancing drug penetration in resistant mycobacterial infections. Significance: The unique cell envelope of mycobacteria is central to survival, enabling it to resist immune defenses and antibiotic treatment. In this study, we reveal a novel function of Ag85A, a synthase of outmost layer of mycobacteria beyond its known role in mycolyltransferase activity: it is essential for the formation of plasma membrane domains that orchestrate cell envelope synthesis. By structuring plasma membrane domains, Ag85A contributes directly to the resilience of the cell envelope, reinforcing mycobacterial survival mechanisms under hostile conditions. Our findings provide a pivotal insight into mycobacterial cell biology, with broad implications for therapeutic development. Disrupting Ag85A-dependent membrane domain formation could weaken the protective cell envelope, offering a promising approach to enhance current treatments.
- Open Access
- 1 August 2025
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 20 (8) , 1962-1979
Systematic Determination of the Impact of Structural Edits on Peptide Accumulation into Mycobacteria
Understanding the factors that influence the accumulation of molecules beyond the mycomembrane of Mycobacterium tuberculosis (Mtb)─the main barrier to accumulation─is essential for developing effective antimycobacterial agents. In this study, we investigated two design principles commonly observed in natural products and mammalian cell-permeable peptides: backbone N-alkylation and macrocyclization. To assess how these structural edits impact molecule accumulation beyond the mycomembrane, we utilized our recently developed Peptidoglycan Accessibility Click-Mediated Assessment (PAC-MAN) assay for live-cell analysis. Our findings provide the first empirical evidence that peptide macrocyclization generally enhances accumulation in mycobacteria, while N-alkylation influences accumulation in a context-dependent manner. We examined these design principles in the context of two peptide antibiotics, tridecaptin A1 and griselimycin, which revealed the roles of N-alkylation and macrocyclization in improving both accumulation and antimicrobial activity against mycobacteria in specific contexts. Together, we present a working model for strategic structural modifications aimed at enhancing the accumulation of molecules past the mycomembrane. More broadly, our results also challenge the prevailing belief in the field that large and hydrophilic molecules, such as peptides, cannot readily traverse the mycomembrane.
- 1 August 2025
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 20 (8) , 1962-1979
Open AccessSystematic Determination of the Impact of Structural Edits on Peptide Accumulation into Mycobacteria
Understanding the factors that influence the accumulation of molecules beyond the mycomembrane of Mycobacterium tuberculosis (Mtb)─the main barrier to accumulation─is essential for developing effective antimycobacterial agents. In this study, we investigated two design principles commonly observed in natural products and mammalian cell-permeable peptides: backbone N-alkylation and macrocyclization. To assess how these structural edits impact molecule accumulation beyond the mycomembrane, we utilized our recently developed Peptidoglycan Accessibility Click-Mediated Assessment (PAC-MAN) assay for live-cell analysis. Our findings provide the first empirical evidence that peptide macrocyclization generally enhances accumulation in mycobacteria, while N-alkylation influences accumulation in a context-dependent manner. We examined these design principles in the context of two peptide antibiotics, tridecaptin A1 and griselimycin, which revealed the roles of N-alkylation and macrocyclization in improving both accumulation and antimicrobial activity against mycobacteria in specific contexts. Together, we present a working model for strategic structural modifications aimed at enhancing the accumulation of molecules past the mycomembrane. More broadly, our results also challenge the prevailing belief in the field that large and hydrophilic molecules, such as peptides, cannot readily traverse the mycomembrane.
- 5 June 2025
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 11 (7) , 1893-1906
The Mycomembrane Differentially and Heterogeneously Restricts Antibiotic Permeation
The recalcitrance of Mycobacterium tuberculosis to antibiotic treatment has been broadly attributed to the impermeability of the organism's outer mycomembrane. However, the studies that support this inference have been indirect or reliant on bulk population measurements. We previously developed the Peptidoglycan Accessibility Click-Mediated AssessmeNt (PAC-MAN) method to covalently trap azide-modified small molecules in the peptidoglycan cell wall of live mycobacteria after they have traversed the mycomembrane. Using PAC-MAN, we now show that the mycomembrane differentially restricts access to fluorophores and antibiotic derivatives. Mycomembranes of both M. tuberculosis and the model organism Mycobacterium smegmatis discriminate between divergent classes of antibiotics as well as between antibiotics within a single family, the fluoroquinolones. By analyzing subpopulations of M. tuberculosis and M. smegmatis, we also found that some fluorophores and vancomycin are heterogeneously restricted by the mycomembrane. Our data indicate that the mycomembrane is a molecule- and cell-specific barrier to antibiotic permeation.
- 5 June 2025
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 11 (7) , 1893-1906
The Mycomembrane Differentially and Heterogeneously Restricts Antibiotic Permeation
The recalcitrance of Mycobacterium tuberculosis to antibiotic treatment has been broadly attributed to the impermeability of the organism's outer mycomembrane. However, the studies that support this inference have been indirect or reliant on bulk population measurements. We previously developed the Peptidoglycan Accessibility Click-Mediated AssessmeNt (PAC-MAN) method to covalently trap azide-modified small molecules in the peptidoglycan cell wall of live mycobacteria after they have traversed the mycomembrane. Using PAC-MAN, we now show that the mycomembrane differentially restricts access to fluorophores and antibiotic derivatives. Mycomembranes of both M. tuberculosis and the model organism Mycobacterium smegmatis discriminate between divergent classes of antibiotics as well as between antibiotics within a single family, the fluoroquinolones. By analyzing subpopulations of M. tuberculosis and M. smegmatis, we also found that some fluorophores and vancomycin are heterogeneously restricted by the mycomembrane. Our data indicate that the mycomembrane is a molecule- and cell-specific barrier to antibiotic permeation.
- Open Access
Mycobacterium tuberculosis MutT4 is an RNA pyrophosphohydrolase that forms biomolecular condensates and sensitizes mRNAs to degradation
Bacterial adaptation to stress involves changes in transcription and mRNA degradation rates. In Escherichia coli , the Nudix hydrolase RppH initiates mRNA degradation by removing pyrophosphate from mRNA 5’-ends, converting 5’-triphosphates to 5’-monophosphates. We aimed to identify the RppH homolog in the globally important pathogen Mycobacterium tuberculosis (Mtb). We deleted each non-essential Nudix gene from Mtb to determine their impacts on mRNA phosphorylation states. Deletion of mutT4 (Rv3908) increased the relative abundance of 5’-triphosphates on myriad mRNAs across the transcriptome. Purified MutT4 converted mRNA 5’-triphosphates into monophosphates, and stimulated degradation by RNase E and RNase J. MutT4 has intrinsically disordered regions (IDRs), a common domain for biomolecular condensate formation. Microscopy showed that MutT4 forms condensates that dissociate upon addition of rifampicin, and that the N-terminal IDR is sufficient for condensate formation. These MutT4 condensates localize with RNase E and RNase J. Deletion of mutT4 in Mtb leads to a higher outer membrane permeability and resistance to oxidative stress. We conclude that MutT4 is the RppH homolog of Mtb, assembling in condensates that may act as degradation hubs. Our data indicate that MutT4 is unlikely to participate in DNA repair or nucleotide pool cleansing, and as such would more accurately be named RppH.
Open AccessMycobacterium tuberculosis MutT4 is an RNA pyrophosphohydrolase that forms biomolecular condensates and sensitizes mRNAs to degradation
Bacterial adaptation to stress involves changes in transcription and mRNA degradation rates. In Escherichia coli , the Nudix hydrolase RppH initiates mRNA degradation by removing pyrophosphate from mRNA 5’-ends, converting 5’-triphosphates to 5’-monophosphates. We aimed to identify the RppH homolog in the globally important pathogen Mycobacterium tuberculosis (Mtb). We deleted each non-essential Nudix gene from Mtb to determine their impacts on mRNA phosphorylation states. Deletion of mutT4 (Rv3908) increased the relative abundance of 5’-triphosphates on myriad mRNAs across the transcriptome. Purified MutT4 converted mRNA 5’-triphosphates into monophosphates, and stimulated degradation by RNase E and RNase J. MutT4 has intrinsically disordered regions (IDRs), a common domain for biomolecular condensate formation. Microscopy showed that MutT4 forms condensates that dissociate upon addition of rifampicin, and that the N-terminal IDR is sufficient for condensate formation. These MutT4 condensates localize with RNase E and RNase J. Deletion of mutT4 in Mtb leads to a higher outer membrane permeability and resistance to oxidative stress. We conclude that MutT4 is the RppH homolog of Mtb, assembling in condensates that may act as degradation hubs. Our data indicate that MutT4 is unlikely to participate in DNA repair or nucleotide pool cleansing, and as such would more accurately be named RppH.
- Open Access
- 12 May 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (20)
Trehalose dimycolate inhibits phagosome maturation and promotes intracellular Mycobacterium tuberculosis growth via noncanonical SNARE interactions
Mycobacterial cell envelopes are rich in unusual lipids and glycans that play key roles during infection and vaccination. The most abundant envelope glycolipid is trehalose dimycolate (TDM). TDM compromises the host response to mycobacterial species via multiple mechanisms, including inhibition of phagosome maturation. The molecular mechanism by which TDM inhibits phagosome maturation has been elusive. We find that a clickable, photoaffinity TDM probe recapitulates key phenotypes of native TDM in macrophage host cells and binds several host Soluble N-ethylmaleimide-Sensitive Factor Attachment Proteins Receptor (SNARE) proteins, including Vesicle Transport through Interaction with t-SNAREs 1B (VTI1B), Syntaxin 8 (STX8), and Vesicle-Associated Membrane Protein 2 (VAMP2). VTI1B and STX8 normally promote endosome fusion by forming a complex with VAMP8. However, in the presence of Mycobacterium tuberculosis , VTI1B and STX8 complex with VAMP2, which in turn decreases VAMP8 binding. VAMP2 acts together with mycolate structure to inhibit phagosome maturation and promotes intracellular M. tuberculosis replication. Thus one mechanism by which TDM constrains the innate immune response to M. tuberculosis is via noncanonical SNARE complexation.
- 12 May 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (20)
Open AccessTrehalose dimycolate inhibits phagosome maturation and promotes intracellular Mycobacterium tuberculosis growth via noncanonical SNARE interactions
Mycobacterial cell envelopes are rich in unusual lipids and glycans that play key roles during infection and vaccination. The most abundant envelope glycolipid is trehalose dimycolate (TDM). TDM compromises the host response to mycobacterial species via multiple mechanisms, including inhibition of phagosome maturation. The molecular mechanism by which TDM inhibits phagosome maturation has been elusive. We find that a clickable, photoaffinity TDM probe recapitulates key phenotypes of native TDM in macrophage host cells and binds several host Soluble N-ethylmaleimide-Sensitive Factor Attachment Proteins Receptor (SNARE) proteins, including Vesicle Transport through Interaction with t-SNAREs 1B (VTI1B), Syntaxin 8 (STX8), and Vesicle-Associated Membrane Protein 2 (VAMP2). VTI1B and STX8 normally promote endosome fusion by forming a complex with VAMP8. However, in the presence of Mycobacterium tuberculosis , VTI1B and STX8 complex with VAMP2, which in turn decreases VAMP8 binding. VAMP2 acts together with mycolate structure to inhibit phagosome maturation and promotes intracellular M. tuberculosis replication. Thus one mechanism by which TDM constrains the innate immune response to M. tuberculosis is via noncanonical SNARE complexation.
- Open Access
- 14 April 2025
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 11 (5) , 1233-1245
A Photoactivatable Free Mycolic Acid Probe to Investigate Mycobacteria–Host Interactions
Mycolic acids are long-chain, α-branched, β-hydroxylated fatty acid lipids that populate the outer mycomembrane of mycobacteria, including the pathogen Mycobacterium tuberculosis. Mycolic acids predominantly occur in the form of glycolipids, but nonglycosylated free mycolic acids (fMA), which are generated during mycomembrane remodeling, are major constituents of the M. tuberculosis biofilm extracellular matrix and promote host immune evasion during M. tuberculosis infection. However, our understanding of these processes is nascent, and there is limited information about the fMA-protein interactions involved. To facilitate such studies, we synthesized a fMA analogue probe (x-Alk-MA) containing a photo-cross-linking diazirine and a clickable alkyne to enable live-cell capture and analysis of protein interactors. The synthetic strategy featured asymmetric hydrogenation to establish the β-hydroxy group, diastereoselective alkylation to establish the α-branch, and late-stage modification to install the functional tags. In macrophages, x-Alk-MA recapitulated the cytokine response of native MA and selectively photolabeled TREM2, a host cell receptor for fMAs that suppresses macrophage activation and has been implicated in M. tuberculosis immune evasion. The synthetic strategy, chemical probes, and photolabeling methods disclosed herein should facilitate future studies aimed at understanding the roles of fMA in mycobacterial physiology and pathogenesis.
- 14 April 2025
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 11 (5) , 1233-1245
Open AccessA Photoactivatable Free Mycolic Acid Probe to Investigate Mycobacteria–Host Interactions
Mycolic acids are long-chain, α-branched, β-hydroxylated fatty acid lipids that populate the outer mycomembrane of mycobacteria, including the pathogen Mycobacterium tuberculosis. Mycolic acids predominantly occur in the form of glycolipids, but nonglycosylated free mycolic acids (fMA), which are generated during mycomembrane remodeling, are major constituents of the M. tuberculosis biofilm extracellular matrix and promote host immune evasion during M. tuberculosis infection. However, our understanding of these processes is nascent, and there is limited information about the fMA-protein interactions involved. To facilitate such studies, we synthesized a fMA analogue probe (x-Alk-MA) containing a photo-cross-linking diazirine and a clickable alkyne to enable live-cell capture and analysis of protein interactors. The synthetic strategy featured asymmetric hydrogenation to establish the β-hydroxy group, diastereoselective alkylation to establish the α-branch, and late-stage modification to install the functional tags. In macrophages, x-Alk-MA recapitulated the cytokine response of native MA and selectively photolabeled TREM2, a host cell receptor for fMAs that suppresses macrophage activation and has been implicated in M. tuberculosis immune evasion. The synthetic strategy, chemical probes, and photolabeling methods disclosed herein should facilitate future studies aimed at understanding the roles of fMA in mycobacterial physiology and pathogenesis.